Evidence mounts linking aspirin to lower risk of ovarian cancer

A new study found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users. The research also found that women who were heavy users of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) over a long period of time had a higher risk of developing ovarian cancer.